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Abstract: A graphene oxide (GO)-based cortisol biosensor was developed to accurately detect cortisol concentrations from sweat samples at point-of-care (POC) sites. A reference electrode, counter
electrode, and working electrode make up the biosensor, and the working electrode was functionalized using multiple layers consisting of GO and antibodies, including Protein A, IgG, and anti-Cab.
Sweat samples contact the anti-Cab antibodies to transport electrons to the electrode, resulting in an
electrochemical current response. The sensor was tested at each additional functionalization layer
and at cortisol concentrations between 0.1 and 150 ng/mL to determine how the current response
differed. A potentiostat galvanostat device was used to measure and quantify the electrochemical
response in the GO-based biosensor. In both tests, the electrochemical responses were reduced in
magnitude with the addition of antibody layers and with increased cortisol concentrations. The
proposed cortisol biosensor has increased accuracy with each additional functionalization layer, and
the proposed device has the capability to accurately measure cortisol concentrations for diagnostic
purposes.
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1. Introduction
Among the many hormones in circulation throughout the body, cortisol (C21 H30 O5 ) is
one of the most influential hormones affecting the physiological processes that alter the
human body’s homeostasis. Cortisol is classified as a steroid hormone that is synthesized
from cholesterol in the zona fasciculata of the kidneys’ adrenal complexes, and it is key to
the body’s fight-or-flight state when a stressor occurs [1]. Hence, cortisol has a reputation
of being the stress hormone [2]. Under ideal homeostasis, cortisol levels will fluctuate in a
day-long cycle, peaking in the morning, and the hormone is released from an unexpected
change experienced [3]. As such, cortisol can reach concentrations in the body that are
too large or small, resulting in unforeseen effects that may indicate that the glucocorticoid
feedback inhibition cycle is impaired [4].
In other studies, cortisol has also been associated with several common stress-based
diseases and other disorders. A review conducted by Kiesner and Granger attempted
to see if cortisol dysfunction correlated with the onset of premenstrual syndrome and
premenstrual dysphoric disorder (PMS/PMDD), but further study was warranted to obtain
more conclusive findings [5]. Wei et al. found that cortisol levels in hair samples increased in
patients with first-episodic depression, which indicates that cortisol may be a biomarker for
depression [6]. Furthermore, a study conducted by Ettman et al. found that depression rates
tripled since the onset of the COVID-19 pandemic, making it much more relevant now [7].
Yang et al. found that individuals with Autism Spectrum Disorder (ASD) had higher
cortisol and serotonin levels while having lower oxytocin [8]. With increased awareness
and criteria changes for ASD diagnoses, cortisol has become more relevant in analyzing
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ASD. In addition, an influx of evidence suggests that cortisol may be a contributing factor
to coronary heart disease (CHD) if it is present in large volumes, especially if maternal
cortisol is present during pregnancy [9]. Relatively minor symptoms can also originate
from higher and lower cortisol levels affecting (and undermining) the immune system,
including insomnia, fatigue, and headaches [10]. Thus, it is necessary to accurately measure
cortisol levels at any time of the day while reducing the difficulty in finding cortisol levels.
It is vital to have an accurate measurement at the point of care (POC) to ensure the
tested patient’s proper diagnosis and prognosis. Current methods of cortisol testing, such
as blood, urine, and saliva tests, are used to detect at least the 10% of cortisol present freely
in the blood with methods including immunoassays and liquid chromatography-tandem
mass spectrometry (LC-MS/MS) [2,11]. However, it can be a relatively time-consuming
process, and some methods must be conducted away from home at an expense to the
patient. Furthermore, these tests must be completed at specific times because cortisol levels
are ideally higher in the morning and lower in the evening [3]. Apart from collecting
a blood sample at a particular time of day, medical professionals may need the patient
to collect all their urine in a 24-h period. Some saliva samples may need to be collected
at multiple periods throughout the day. These tests are prone to inaccuracies due to the
design of the interface between cortisol and quantitative scales for analysis, such as Cohen’s
perceived stress scale (PSS) [12]. The result is an overall cost of time and convenience to
the patient and healthcare system. However, E. Russel et al. found that cortisol levels in
bodily sweat are comparable to those in saliva samples, which indicates that sweat and
hair samples could accurately reflect the concentration of cortisol in the body [13].
In recent years, additional research in bio-interfaces has increased for biosensor applications for several different material types. Among these materials, graphene has been a
material of interest to researchers and government entities for over four decades [14]. Significant resources and funding have been invested, where the British government alone has
invested over 20 million GBP in developing graphene products [15]. The fabled material
possesses unique mechanical properties, such as a considerably high mechanical strength
of 1 TPa, and it has already seen research and applications for solar cells and nanoelectronic
devices [16]. Other mechanical properties associated with graphene include its thermoconductivity and charge carrier-mobility, measured to be 3000 W/mK and 10,000 cm2 /V·s,
respectively [16]. One specific variation of graphene comes in the form of graphene oxide
(GO), a graphene-based material with oxygen functional groups covalently attached. GO
has garnered international interest since the mid-2000s due to the material’s mechanical,
electrical, and thermal applications, and it, along with reduced graphene oxide (rGO),
has been tested for electrochemical sensors [17]. GO is now a commonplace material for
self-assembling monolayers (SAMs), and its properties allow for easy functionalization
with other chemicals and biomolecules [18]. This is further justified with GO’s high surface
area to volume ratio—specifically a surface area of approximately 2630 m2 /g—and its
ability to function well in aqueous environments [19]. The larger surface area makes it
possible for more biomolecules to be functionalized more efficiently. GO is also ideal for
medical devices if the sample used on the said device is a liquid (i.e., sweat). The use of
GO has been associated with increased specificity in what electrodes and other biological
molecules are detected in a sensor, and that application has been exploited in several past
studies focusing on cortisol detection and analysis.
Several vital proteins and carbohydrates found in the body can be used as a base to
analyze a patient’s physiology. These sensors can detect minute variations in concentrations of various hormones, proteins, and chemicals in real-time with high sensitivity and
specificity to their respective applications. An electrode can be designed by coating it in
GO and adding specific antibodies to the surface, providing the specificity required by a
biosensor [16,20]. Glucose sensors have been designed for research using graphene as done
by S. Chaiyo et al., where they developed a paper-based biosensor to detect glucose levels
in serum samples [21]. S. Cinti et al. developed a biosensor that detects chloride ions (Cl− )
using screen-printed filter paper with hydrophilic and phobic sites coated in a sulfuric acid
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solution with Cl− ions [22]. A lactate biosensor from K. Lin et al. used GO nanosheets
coated in a dimethyl-sulfoxide (DMSO) and 1-pyrenebutyric acid–N-hydroxysuccinimide
ester (PANHS) to detect lactate concentrations in sweat samples [23]. Concerning cortisol,
one application explored by S. Tuteja et al. included a Bluetooth-based means to obtain data
from an electro-reduced graphene oxide (e-RGO) sensor using an anti-cortisol antibody
CORT-2 and a lactate antibody to detect and isolate cortisol in sweat samples [20]. In
addition, more cortisol biosensors were designed by M. Sekar et al. using a conductive
carbon fiber material to detect cortisol levels in sweat, and their findings indicated that the
sensor was sensitive and specific enough to be properly used specifically for near-complete
cortisol detection [24]. A GO biosensor using π-stacked rabbit anti-cortisol antibodies and
denatured bovine serum albumin (d-BSA) was created by K. Kim et al. to detect cortisol in
saliva samples by utilizing the antibodies’ specificity to detect the hormone [10].
The previously mentioned GO-biosensors maintained their capacities to detect cortisol
in serum, sweat, and saliva samples to inform users of potential physiological changes and
abnormalities affecting them. To provide a convenient, non-invasive, and swift cortisol
test for diagnostic and personalized care applications, research in a sweat-based cortisol
biosensor was conducted. With the varying cortisol concentrations throughout the body
in mind, this research intended to determine whether a GO interface’s electrochemical
responses were affected by those concentrations. These differences in the electrochemical
responses based on cortisol concentration may be a determining factor in developing a
user-friendly cortisol biosensor for applications at the POC.
2. Materials and Methods
2.1. Device Principles
The GO-based cortisol biosensor is a chemical-sensing device consisting of three
electrodes to determine cortisol concentration in the body based on sweat samples. The
principal workings of the biosensor are shown below in Figure 1. The device would include
a transducer to convert a change in the biological response to an electric signal, including
biological elements to detect these changes. In this case, the biosensor is designed to
include antibodies. The GO-based sensor also consists of an electrode system using a 3 mm
carbon-coated working electrode (WE) and a reference and counter electrode (RE and
CE, respectively), which are coated in silver/silver chloride (Ag/AgCl). These Ag/AgCl
electrodes were used as the device’s electrochemical transducer by converting physiological
changes from sweat samples to a current. The current is also proportional to the cortisol
concentration in each sweat sample, indicating that the current will be larger in magnitude
as cortisol concentrations are increasing. The sensor is also paper-based to eliminate any
use of an external power source but instead relies on capillary action and filtering to achieve
similar results.
That said, using GO in this biosensor has a number of advantages and disadvantages
to consider. As previously mentioned, GO has a large surface area and is a fabulous
conductor of electricity. However, the latter also comes with the drawback of its lack of a
band gap—the inability to “switch off” the GO once it begins conducting electricity—due
to graphene’s two-dimensional honeycomb lattice structure [25]. Another point of concern
for the proposed device is graphene’s susceptibility to oxidative reactions. Although it is
oxidized into GO, repeated usage of the biosensor could leave the WE exposed to more
oxidative reactions. There are also concerns regarding the possible toxicity of graphene, as
there is the possible chance of complications, ranging from irritation and allergic reactions
to interactions with dermal proteins [26]. To overcome these obstacles, the sensor was
paper-based and intended to be used once to minimize any possible toxic exposure to the
skin and oxidizing reactions from the sweat or other biomolecules or chemicals on the skin.
It should be noted that the GO on the WE was not directly in contact with the skin but
rather the antibodies that were functionalized onto it were.

2022, 21, x FOR PEER REVIEW

Sensors 2022, 22, 558

4 of 12

the skin. It should be noted that the GO on the WE was not directly in contact with the
skin but rather the antibodies that were functionalized onto it were.

4 of 12

Figure 1. A conceptual graphical abstract of the functionality of the graphene oxide-based biosensor
Figure 1. A conceptual graphical abstract of the functionality of the graphene oxide-based biosensor
in detecting sweat cortisol for diagnostic purposes.
in detecting sweat cortisol for diagnostic purposes.
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prepared using a 1.99 mg/mL anti-rabbit IgG stock solution by collecting and dispensing
exactly 80.402 µL of the latter solution into 919.598 µL 1% filtered BSA solution.
Once Protein A was fully activated, 10 µL of the Protein A with EDC/sulfo-NHS
solution was dispensed onto the WE to bind the Fc binding site on Protein A with the
IgG antibody. The Protein A and IgG antibodies were set to incubate at room temperature
for an hour, followed by washing the WE with PBS as previously mentioned. A total of
10 µL of anti-Cab antibodies were dispensed onto the WE, incubated for one hour at room
temperature, and similarly washed with PBS. The final layer of the WE was prepared using
varying cortisol concentrations in PBS solution, including 0.1, 1, 10, 50, and 150 ng/mL, and
it was set to incubate at room temperature for 30 min. These varying concentrations were
prepared in a Tween-20 and PBS solution. The same PBS washing technique was performed
on the WE following incubation. A solution of potassium ferricyanide (K3 [Fe(CN)6 ]) in
PBS was prepared as an electrolyte solution for experimentation. The electrodes were
coated with the redox moiety solution to hinder electron transfer to the electrode while
measurements were taken.
2.3. Experimental Procedures
The cortisol sensors underwent Raman spectroscopy measurements to determine the
effectiveness of binding the antibodies onto the screen-printed WE. Three variations of
the biosensors were used for the Raman measurements: the sensor with only GO, the
sensor with antibodies and GO, and the sensor with only antibodies. A Jobin Yvon Raman
LabRAM HR800 System (confocal microscope, 300–1800 g/mm gratings, full area CCD
detector, SWIFT-Scan, Horiba, Kyoto, Japan) was used to collect the measurements. All
three measurements were done using a 532 nm green laser focused on a point on the
electrode. Furthermore, the grating and filter settings were changed, and a 100× lens was
used to focus the laser onto the sensors.
Each cortisol sensor underwent cyclic voltammetry (CV) to determine the biosensor’s
most optimal functionalization and design. Four electrodes were prepared for CV measurements: GO + APTES, GO + APTES + Protein A, GO + APTES + Protein A + IgG, and GO
+ APTES + Protein A + IgG + anti-Cab. All CV measurements on the four sensors were
performed using a VersaSTAT 4 Potentiostat Galvanostat (2 A maximum current, 2 µs time
base, 10 µHz–1 MHz frequency range, AMETEK, Inc., Berwyn, PA, USA) with a potential
range of ±0.6 V and a scan rate of 50 mV/s to obtain any well-defined oxidation-reduction
peaks. As a means of control, a cortisol biosensor without GO and a biosensor with GO
added were both tested for CV measurements with the VersaSTAT 4 Potentiostat Galvanostat. Both sensors were functionalized with the same antibodies regardless of whether
they included GO as an initial layer to the WE. They were tested with cortisol samples
with a 0.1 ng/mL concentration. The potential range for this test was also set to ±0.6 V to
demonstrate the viability of GO in the POC biosensor. To determine the effect of cortisol
concentrations on the GO-based biosensor, CV measurements were conducted on the fully
functionalized biosensor once again with the VersaSTAT 4 Potentiostat Galvanostat device
with a ±0.6 V potential range for the experiment. As previously mentioned, five sensors
were tested based on their cortisol concentrations: 0.1, 1, 10, 50, and 150 ng/mL on the WE,
and the redox moiety solution was used as the electrolyte solution for all five variations.
Micrographs of the surface of the working electrode at various stages of functionalization were taken with a Hitachi S-4300N scanning electron microscope system. Specifically,
two samples were imaged: the working electrode with only GO and the working electrode
fully functionalized with all antibodies used. Each sample underwent sputter coating
with gold via a CRC-sputtering system to properly image the electrode’s surface. During
imaging, a 10 kV voltage was used.
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that anti-Cab antibodies
covalent
bonding
to
that
antibodies appear
appearto
tobe
bemostly
mostlyindependent
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bonding
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Figure
Figure 3.
3. Raman
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spectrometry measurements
measurements on
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(a) only
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graphene oxide,
oxide, (b) both graphene oxide and antibodies, and (c) only antibodies.

Sensors 2022,
2022, 22,
21, 558
x FOR PEER REVIEW
Sensors

88 of
12
of 12

3.2. SAMs Optimization Cyclic Voltammetry
Voltammetry Measurements
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redox moieties
moieties
(K33[Fe(CN)66]] in
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±0.6
±
0.6V.
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3.3. Demonstration of GO Effects on the Biosensor
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had
a
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[32].
SEM
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WE
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roughness had a positive correlation with surface area [32]. SEM images of the biosensor’s
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(see
Figure
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a
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surface
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4. Conclusions
A multi-layer functionalized GO-based biosensor with a carbon WE and Ag/AgCl
RE and CE has been proven to determine cortisol concentrations in sweat samples of
varying concentrations accurately. The sensor’s current response’s magnitude consistently
decreased as additional functionalization layers were added and cortisol concentrations
increased. The cortisol concentration in the human body can be distinctively detected at a
given POC with the biosensor as an easy-to-use tool for medical and diagnostic purposes.
The GO-based biosensor has been designed to address the common concerns and flaws
associated with current cortisol detection methods, such as blood and urine analyses. In
summation, the proposed medical device permits the distinct electrochemical responses
required for an accurate and reliable diagnosis based on a detected concentration of cortisol.
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